Loading...
Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
Colistin is administered as its inactive prodrug colistimethate (CMS). Selection of an individualized CMS dose for each patient is difficult due to its narrow therapeutic window, especially in patients with chronic kidney disease (CKD). Our aim was to analyze CMS use in patients with CKD. Secondary...
Na minha lista:
| Udgivet i: | Molecules |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6384574/ https://ncbi.nlm.nih.gov/pubmed/30717123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24030530 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|